Cargando…
Deep-sea fungal metabolites as potential inhibitors of glucose-regulatory enzymes: In silico structure–activity analysis
Chronic diabetes mellites related hyperglycemia is a major cause of mortality and morbidity due to further complications like retinopathy, hypertension and cardiovascular diseases. Though several synthetic anti-diabetes drugs specifically targeting glucose-metabolism enzymes are available, they have...
Autores principales: | Alanzi, Abdullah R., Parvez, Mohammad K., Alqahtani, Moneerah J., Al-Dosari, Mohammed S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587758/ https://www.ncbi.nlm.nih.gov/pubmed/37868645 http://dx.doi.org/10.1016/j.jsps.2023.101776 |
Ejemplares similares
-
In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes
por: Alanzi, Abdullah R, et al.
Publicado: (2023) -
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins
por: Alanzi, Abdullah R, et al.
Publicado: (2023) -
Advances in Fungal Phenaloenones—Natural Metabolites with Great Promise: Biosynthesis, Bioactivities, and an In Silico Evaluation of Their Potential as Human Glucose Transporter 1 Inhibitors
por: Ibrahim, Sabrin R. M., et al.
Publicado: (2022) -
Anti-Biofilm and Antibacterial Activities of Cycas media R. Br Secondary Metabolites: In Silico, In Vitro, and In Vivo Approaches
por: Attallah, Nashwah G. M., et al.
Publicado: (2022) -
Deep Sea Actinomycetes and Their Secondary Metabolites
por: Kamjam, Manita, et al.
Publicado: (2017)